Global X Genomics & Biotechnology ETF
GNOM
GNOM
41 hedge funds and large institutions have $13.9M invested in Global X Genomics & Biotechnology ETF in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.24M | |
| 2 | +$424K | |
| 3 | +$286K | |
| 4 |
WMP
Wealth Management Partners
Tucson,
Arizona
|
+$258K |
| 5 |
Jane Street
New York
|
+$158K |
Top Sellers
| 1 | -$880K | |
| 2 | -$822K | |
| 3 | -$797K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$510K |
| 5 |
ACS
Archford Capital Strategies
Swansea,
Illinois
|
-$281K |
